146 related articles for article (PubMed ID: 37661590)
1. Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta-analysis.
Gong X; Shen L; Xie J; Liu D; Xie Y; Liu D
Helicobacter; 2023 Dec; 28(6):e13011. PubMed ID: 37661590
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori Infection as a Predictor of Treatment Outcomes of Gastric Cancer: A Systematic Review and Meta-Analysis.
Gan C; Wu X; Shen Y; Cao Z; Jing J; Pan W
Dig Dis; 2023; 41(4):553-564. PubMed ID: 36907179
[TBL] [Abstract][Full Text] [Related]
3. Impact of
Noori M; Fayyaz F; Rezaei N
Immunotherapy; 2023 Jun; 15(9):657-667. PubMed ID: 37140002
[TBL] [Abstract][Full Text] [Related]
4. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Che H; Xiong Q; Ma J; Chen S; Wu H; Xu H; Hou B
BMC Cancer; 2022 Aug; 22(1):904. PubMed ID: 35986342
[TBL] [Abstract][Full Text] [Related]
5. Is It a Protective Factor of Helicobacter pylori Infection in Overall Survival of All Gastric Cancer? Evidence from Meta-Analysis.
Zheng F; Sun Z; Kan J; Yin J; Du F; Shen G; Wang Z; Ren D; Bao X; Zhao J
J Environ Pathol Toxicol Oncol; 2017; 36(4):309-320. PubMed ID: 29431063
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Magahis PT; Maron SB; Cowzer D; King S; Schattner M; Janjigian Y; Faleck D; Laszkowska M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899129
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of Helicobacter pylori in gastric cancer patients: A meta-analysis.
Li G; Yu S; Xu J; Zhang X; Ye J; Wang Z; He Y
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):216-224. PubMed ID: 30361060
[TBL] [Abstract][Full Text] [Related]
8. Is there an association between
Ng QX; Foo NX; Loke W; Koh YQ; Seah VJM; Soh AYS; Yeo WS
World J Gastroenterol; 2019 Oct; 25(37):5702-5710. PubMed ID: 31602169
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
10. Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer.
Wang F; Sun G; Zou Y; Zhong F; Ma T; Li X
PLoS One; 2013; 8(5):e62440. PubMed ID: 23667477
[TBL] [Abstract][Full Text] [Related]
11. The association between Helicobacter pylori infection and inflammatory bowel disease in children: A systematic review with meta-analysis.
Kong G; Liu Z; Lu Y; Li M; Guo H
Medicine (Baltimore); 2023 Sep; 102(36):e34882. PubMed ID: 37682136
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta-analysis.
Kale-Pradhan PB; Mihaescu A; Wilhelm SM
Pharmacotherapy; 2015 Aug; 35(8):719-30. PubMed ID: 26173786
[TBL] [Abstract][Full Text] [Related]
13. Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta-analysis.
Ouyang Y; Zhang W; Huang Y; Wang Y; Shao Q; Wu X; Lu N; Xie C
Helicobacter; 2021 Oct; 26(5):e12838. PubMed ID: 34333811
[TBL] [Abstract][Full Text] [Related]
14.
Yu M; Zhang R; Ni P; Chen S; Duan G
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31561576
[No Abstract] [Full Text] [Related]
15. The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta-analysis.
Zhan Y; Si M; Li M; Jiang Y
Helicobacter; 2019 Apr; 24(2):e12562. PubMed ID: 30672065
[TBL] [Abstract][Full Text] [Related]
16. Effects of eradicating Helicobacter pylori on metachronous gastric cancer prevention: A systematic review and meta-analysis.
Fan F; Wang Z; Li B; Zhang H
J Eval Clin Pract; 2020 Feb; 26(1):308-315. PubMed ID: 31141285
[TBL] [Abstract][Full Text] [Related]
17. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
[TBL] [Abstract][Full Text] [Related]
18. Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer: A Systematic Review and Meta-Analysis.
Zhao B; Zhang J; Mei D; Luo R; Lu H; Xu H; Huang B
J Clin Gastroenterol; 2020 Mar; 54(3):235-241. PubMed ID: 30829904
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H
J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
Fontes LES; Martimbianco ALC; Zanin C; Riera R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012357. PubMed ID: 30746681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
